M J Sheardown - JoVE Visualize

Showing results (21-30 of 50) with videos related to

Pageof 5

Sort By:

Pharmacology, Biochemistry, and Behavior|May 1, 1994

Pharmacological profile of a novel neuronal calcium channel blocker includes reduced cerebral damage and neurological deficits in rat focal ischemiaF C Barone, W J Price, P Jakobsen, et al.

Neuropharmacology|February 1, 1985

Selective potentiating effect of beta-p-chlorophenylglutamate on responses induced by certain sulphur-containing excitatory amino acids and quisqualateJ Davies, A A Francis, D J Oakes, et al.

Neuroscience Letters|November 23, 1984

Phosphono dipeptides and piperazine derivatives as antagonists of amino acid-induced and synaptic excitation in mammalian and amphibian spinal cordJ Davies, A W Jones, M J Sheardown, et al.

Biochemical Pharmacology|July 13, 2001

Agonist-induced functional desensitization of recombinant human 5-HT2 receptors expressed in CHO-K1 cellsR H Porter, C S Malcolm, N H Allen, et al.

Diabetes|May 6, 1998

Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formationG M Castillo, J A Cummings, W Yang, et al.

Journal of Medicinal Chemistry|September 10, 1999

N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effectsL J Knutsen, J Lau, H Petersen, et al.

British Journal of Pharmacology|September 28, 1999

Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cellsR H Porter, K R Benwell, H Lamb, et al.

The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997

M1 receptor agonist activity is not a requirement for muscarinic antinociceptionM J Sheardown, H E Shannon, M D Swedberg, et al.

Journal of Medicinal Chemistry|June 12, 1992

Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridinesP Sauerberg, P H Olesen, S Nielsen, et al.

Schizophrenia Research|April 29, 2000

Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and miceH E Shannon, K Rasmussen, F P Bymaster, et al.

Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:

Pageof 5

Pharmacology, Biochemistry, and Behavior|May 1, 1994

Pharmacological profile of a novel neuronal calcium channel blocker includes reduced cerebral damage and neurological deficits in rat focal ischemiaF C Barone, W J Price, P Jakobsen, et al.

Neuropharmacology|February 1, 1985

Selective potentiating effect of beta-p-chlorophenylglutamate on responses induced by certain sulphur-containing excitatory amino acids and quisqualateJ Davies, A A Francis, D J Oakes, et al.

Neuroscience Letters|November 23, 1984

Phosphono dipeptides and piperazine derivatives as antagonists of amino acid-induced and synaptic excitation in mammalian and amphibian spinal cordJ Davies, A W Jones, M J Sheardown, et al.

Biochemical Pharmacology|July 13, 2001

Agonist-induced functional desensitization of recombinant human 5-HT2 receptors expressed in CHO-K1 cellsR H Porter, C S Malcolm, N H Allen, et al.

Diabetes|May 6, 1998

Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formationG M Castillo, J A Cummings, W Yang, et al.

Journal of Medicinal Chemistry|September 10, 1999

N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effectsL J Knutsen, J Lau, H Petersen, et al.

British Journal of Pharmacology|September 28, 1999

Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cellsR H Porter, K R Benwell, H Lamb, et al.

The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997

M1 receptor agonist activity is not a requirement for muscarinic antinociceptionM J Sheardown, H E Shannon, M D Swedberg, et al.

Journal of Medicinal Chemistry|June 12, 1992

Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridinesP Sauerberg, P H Olesen, S Nielsen, et al.

Schizophrenia Research|April 29, 2000

Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and miceH E Shannon, K Rasmussen, F P Bymaster, et al.

Pageof 5